http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4867976-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-83
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 1987-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27d53188192be53afd13663cf2e375cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f2236a06cb4ff88ef6e0ca424db428c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e5affc464bbfc6b81cf56c2f833450
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ad9939478a375f5a450e5aa9626195
publicationDate 1989-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4867976-A
titleOfInvention H.I.V. treatment utilizing specific inhibitation of protein syntheses in a cell
abstract A method for treatment of acquired immuno-deficiency syndrome (AIDS) which comprises administering a therapeutically effective amount of liposomes containing a toxin which specifically inhibits the protein synthesis in cells to a patient with AIDS.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6060082-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5554528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5306631-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7459290-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5080906-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6387397-B1
priorityDate 1987-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0247873-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4638049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240346-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4709017-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136010750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706

Total number of triples: 43.